roginolisib
iOnctura
['melanoma']
first-in-human (fih) phase i dose escalation study (part a) of the first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (pi3k ) roginolisib in patients with advanced cancer and dose confirmation in uveal melanoma (part b). #asco23 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News